Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 60,000 | reported | 03 Dec 2007 | tx 1+60,000 |
| NEXMED INC | 50,000 | reported | 04 Jan 2018 | tx 19+387,011−44,265 |
| Zosano Pharma Corp | 23,596 | reported | 10 Jun 2021 | tx 12+197,760 |
| ANADYS PHARMACEUTICALS INC | 15,000 | reported | 27 May 2011 | tx 91+106,250−116,241 |
| Regulus Therapeutics Inc. | 8,287 | reported | 21 Apr 2015 | tx 88+1,168,189−959,110 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jun 2021 | GRANT_AWARD | Zosano Pharma Corp | 15,000 | 0.00 USD | |
| 10 Jun 2021 | GRANT_AWARD | Zosano Pharma Corp | 30,000 | 0.00 USD | deriv |
| 25 Jun 2020 | GRANT_AWARD | Zosano Pharma Corp | 7,500 | 0.00 USD | |
| 03 Jun 2020 | GRANT_AWARD | Zosano Pharma Corp | 15,000 | 0.00 USD | deriv |
| 02 Jan 2019 | GRANT_AWARD | Zosano Pharma Corp | 1,500 | 0.00 USD | deriv |
| 31 May 2018 | GRANT_AWARD | Zosano Pharma Corp | 25,000 | 0.00 USD | deriv |
| 02 Jan 2018 | GRANT_AWARD | Zosano Pharma Corp | 30,000 | 0.00 USD | deriv |
| 04 Jan 2018 | GRANT_AWARD | NEXMED INC | 50,000 | 0.00 USD | deriv |
| 05 Jan 2017 | GRANT_AWARD | NEXMED INC | 15,000 | — | |
| 02 Nov 2016 | GRANT_AWARD | Zosano Pharma Corp | 20,000 | 0.00 USD | deriv |
| 30 Sept 2016 | GRANT_AWARD | NEXMED INC | 16,997 | 0.34 USD | |
| 19 Aug 2016 | PURCHASE | Zosano Pharma Corp | 15,920 | 1.32 USD | |
| 19 Aug 2016 | PURCHASE | Zosano Pharma Corp | 15,920 | 0.13 USD | deriv |
| 19 Aug 2016 | PURCHASE | Zosano Pharma Corp | 15,920 | 0.13 USD | derivfirst after silence |
| 30 Jun 2016 | GRANT_AWARD | NEXMED INC | 14,393 | 0.40 USD | |
| 05 Apr 2016 | GRANT_AWARD | NEXMED INC | 8,621 | 0.58 USD | |
| 04 Jan 2016 | GRANT_AWARD | NEXMED INC | 50,000 | 0.00 USD | deriv |
| 21 Apr 2015 | SALE | Regulus Therapeutics Inc. | 60,000 | 17.73 USD | |
| 21 Apr 2015 | EXERCISE | Regulus Therapeutics Inc. | 60,000 | 0.38 USD | |
| 20 Apr 2015 | EXERCISE | Regulus Therapeutics Inc. | 66,071 | 0.38 USD | |
| 17 Apr 2015 | SALE | Regulus Therapeutics Inc. | 73,929 | 16.94 USD | |
| 17 Apr 2015 | EXERCISE | Regulus Therapeutics Inc. | 73,929 | 0.38 USD | |
| 20 Apr 2015 | SALE | Regulus Therapeutics Inc. | 66,071 | 16.85 USD | |
| 21 Apr 2015 | EXERCISE | Regulus Therapeutics Inc. | 60,000 | 0.00 USD | deriv |
| 20 Apr 2015 | EXERCISE | Regulus Therapeutics Inc. | 66,071 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 19 Aug 2016.